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SELF.MEASURED BLOOD PRESSURE vs ABPM IN
THE DIAGNOSIS OF HYPERTENSION.1LHllJm, J. Steurer,
W. Vetter", Department of Internal Medicine, University Hospital,
Zurich, Switzerland.
Both, ambulatory blood pressure (ABPM) and blood pressure self-
measurement (SM) are used in the diagnostic work-up of hypertension.
In the present study the validity of SM was compared with ABPM. 79
patients with mild hypertension were included. ABPM was performed by
using a Space-Labs device (90 207), SM with a semiautomatic oscil1o-
metric device (Visomat OZ2). In group I patients (n=48) performed I
single daily morning SM (6a.m.-8a.m.) and in group 2 (n=31) 2 SM in
the morning (6 a.m.-8 a.m.) and 2 in the evening (6p.m.-8p.m.). In each
group SM values of day 1-3 and 4-7(8) were pooled. ABPM was
performed at day I and day 7. Dipping was defmed as a decrease in mean
night systolic and/or diastolic blood pressure of ~ 10%. In group I
mean SM blood pressure values were 143±14 in the first and I42±15
mmHg systolic in the second period and 92±1 I and 90±11 mmHg
diastolic, in group 2 142±19 and I39±I7 mmHg systolic and 9Q±12and
89±I2 mmHg diastolic. Respective values for ABPM-day were in
groupI 141±1I at day I and 142±12 mmHg systolic at day 7 and 91±8
and 9I±9 mmHg diastolic. Only 3 of the 7l (4.2%) cases showed a non-
dipping 24h-ABPM profile. In SM the standard deviation of the mean
difference (SOD) decreased from group I to group 2 from 9.9 to 7mmHg
systolic and 6 to 5 mmHg diastolic. In ABPM no decrease was observed
in SOD: 5.3 and 7.3 mmHg systolic and 4.8 and 5 mmHg diastolic. In
SM correlations coefficients (r) between the first and the second period
increased from 0.58 to 0.86 systolic and from 0.7 to 0.85 diastolic. In
ABPM the respective values were 0.78 and 0.6 systolic and 0.68 and
0.67 diastolic.
The following conclusions can be drawn from our results 1. The nearly
identical values in mean blood pressure, SOD and correlations
demonstrate, that SM is as precise as ABPM when multiple daily
measurements are performed. 2. ABPM is the only method to detect
non-dipping. However, in our patients with mild uncomplicated
hypertension this phenomen was very rare. 3. Because of the easier
application of SM in general practice and its higher acceptance in
patients, SM is a good candidate in replacing ABPM in the routine
diagnostic work-up of hypertension.
Key Words: Hypertension, self-measurement, ABPM
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LONG-TERM FOLLOWUP OF UNTREATED WHITE-
COAT HYPERTENSIVE PATIENTS. William B. White •
Wendy Susser, Ellen 1. McCabe, and George A Mansoor, Section
of Hypertension and Vascular Diseases, University of
Connecticut Health Center, Farmington, CT
Recent cross-sectional and prognostic studies of white-coat
hypertension (WCH) have suggested that an office BP > 140/90
mmHg is not predictive of hypertensive morbidity when the
awake ambulatory BP is < 135/85 mmHg. To evaluate the long-
term changes in office and ambulatory BP, and the white-coat
effect (office-awake BP), we restudied untreated WCH patients
(office BP > 140/90 mmHg with awake BP < 135/85 mmHg and
white-coat effect> 20 mmHg systolic or 10 mmHg diastolic)
who had their first ambulatory BP recording > 12 months
previously and had not been treated with antihypertensive drug
therapy. Recordings were performed with either Accutracker or
QuietTrak recorders under the same environmental conditions.
Patients with substantial changes in employment status (e.g,
retirement), weight/exercise (> 10 % change), or drugs that might
affect BP were excluded. Studies were performed 37 ±26 months
(range, 15-119 months) apart:
~ Study I --Sn!lh.1 D-value
OfficeSBP(mmHg) 148±13 149±12 .647
Office OBP (mmHg) 99 ± 6 96 ± 7 .115
24-h SBP (mmHg) 120± 5 123± 7 .045'
24-h OBP (mmHg) 73 ± 5 77 ± 7 .009'
AwakeSBP(mmHg) 126± 6 128± 9 .336
AwakeDBP(mmHg) 78±5 81±8 .051'
Sleep SBP (mmHg) 104± 7 106± 7 .200
Sleep DBP (mmHg) 62 ± 6 66 ± 6 .004'
White-coat effect-(%) 100% 95 % .919
·white coat effect (office - awake BP > 20mmH. SBP or 10 mmH. OBP)
Only five (12.5%) of the WCH patients developed one or more
criteria for ambulatory hypertension (awake BP > 135/85 mmHg
or BP load> 30%). Age, duration of hypertension, body mass
index, baseline office and ambulatory BPs, and time lapsed
between studies did not predict the change in ambulatory BP over
time. These data show that 88% of patients with WCH remain as
WCH over time and 95% continue to display a white-coat effect.
The small subgroup who did become hypertensive over time
were not predicted by office BP, ambulatory BP, or age.
Key Words: white-coat hypertension, ambulatory BP,
white-coat effect, outcomes
POSTERS: Patient Evaluation and Management 8SA
G14
MICROALBUMINURIA, LEFT VENTRICULAR MASS AND AMBULATORY
BLOOD PRESSUREIN ESSENTIALHYPERTENSION.
J RedOn, E Baldo, V Bertolln, JV Lozano, A Miralles, JM Pascual.
Hypertension Clinic. Department of Medicine. Hospital 01SagunlO,Spain.
Microalbuminurla (MALB) is a potential marker of risk in essential
hypertension. Previously MI describe a relationship between MALB and left
ventricular mass (LVM) independent of office BP values. Oblectlve: To
assess il Ihe relationship between MALB and LVM is independent of a more
representative BP values as such the ambulatory BP. Design and
~.Patients wilh essential hypertension. aged 25 to 50 years old, never
hated with antihypertensive drugs, MIre Included in Ihe study. Theincluslon
critsria was: a) absence of diabetes, renal disease or urinary tract infection:
b) echocardiography suitable lor measurement of LVM; c) Urinary e1bumin
excretion (UAE)was estimated in urine of 24 hour in two separated deys and
d) good quality ambulalOl)' blood pressura monitoring during 24 hours. LVM
was calculated by Ihe Devereaux formula and relered 10 height (LVMI glm).
UAE was measured using a immunonephelomelric assay (Behring Institue)
and MALB was considered when UAE23Omgl24hIn Ihe two days. AMBP was
performed using an oscilomelric device (Specelabs 90202 or 90207) dUring a
regUlarworking day. Readings MIre prograrnmedevel)' 20 min belw8en6 an
to midnight and thereafter evel)' :lO min. Mean 01 24 hours, awake and sleep
periods for systolic and diastolic blood pressure \lY8recalculated.~.
One hundred and lifthy one petienls (96 male, mean age 37±6 yr, BMI
27.7±3.7 glm2) were included. The mean values 01 UAE was 30.1±52.3
mg/24h and Ihe LVMI 140.6±44.1g/m. The percentage 01MALB was 28% and
LV hypertrophy 34%. A signillcant relationship between UAE and LVMI was
observed indepedent of diastolic ambulatory BPt age and sex. The
rQlataonship is show in the figure.
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Conclusions. Patients with essential hypertension and MALB had higher LV
mass at the same diastolic BP values. Assessment of MALBcan be useful for
stratification of risk on hypertensives
microalbuminuria, left ventricular hypertrophy, ambulatory
blood pressure, essential hypertension
INAPPROPRIATE PHYSICIAN PRESCRIBING HABITS
OF ORAL NIFEDIPINE CAPSULES IN HOSPITALIZED
PATIENTS. Faiz Rehman, George A. Mansoor, and William
B. White,* Section of Hypertension and Vascular Diseases,
University of Connecticut School of Medicine, Farmington,
Connecticut.
Despite the absence of an approved FDA indication, the use of
oral/sublingual nifedipine for 'acute' hypertension has become a
widespread practice among physicians. To assess the clinical
circumstances for which the drug was being prescribed, dosing of
oral nifedipine capsules was studied prospectively in three central
Connecticut hospitals (private-nonteaching, university, and
community-teaching). Through evaluation of computerized
pharmacy and medical records, data were collected on diagnostic
reasons for ordering nifedipine, pre- and post-treatment BPs,
dosing frequency, clinical documentation associated with drug
prescription, and adverse events. Physicians and nurses at the
respective hospitals were unaware of the conduct of the study. The
prevalence of nifedipine capsule administration for all 3 hospitals
was 3.4% (152 dosings/4498 hospitalized patients/2 months).
Practice habits and BP changes did not differ among hospitals. Ten
mg was the most common dose prescribed (96%), however,
multiple doses were given in 63% of cases. Sixty-three per cent of
nifedipine orders were given over the phone for arbitrary and
asymptomatic BP elevations and 2ll1!! of orders lacked bedside
patient evaluation. Followup of BP was performed within I hour in
51 % of patients, 24% in 2 hours while in 25%, there was no
documentation of followup until 2-6 hours after nifedipine dosing.
Mean pretreatment BP was 186/94 ± 20116 mm Hg, (range, 150/50
to 2501125 mmHg). Blood pressure fell -32/-16 ± 22/16 mm Hg
(range, -92/-90 to +8/+28 mmHg) and was related to the level of
pretreatment BP (r = 0.53, p < 0.0001 for systolic BP, and r =
0.49, P < 0.0001 for diastolic BP). Large, asymptomatic BP
reductions were common (prevalence> 30115mmHg = 66%). One
hypertensive patient with angina experienced severe hypotension
accompanied by myocardial infarction. These data demonstrate
inappropriate prescribing habits of oral nifedipine in hospitalized
patients characterized by lack of proper assessment prior to drug
dosing, highly arbitary treatment parameters that were written
without regard for symptoms, and slow followup for evaluation of
clinical response.
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